P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
MDXG | N/A | N/A | N/A | +80.67% |
MDXG Peer | N/A | N/A | N/A | +41.62% |
Biotechnology Industry | 18.4 | 17.1 | 0.4 | +643.73% |
Health Technology Sector | 31.8 | 20.9 | 0.6 | +119.23% |
S&P 500 Market | 31.2 | 30.9 | 1.0 | +100.97% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.06 | -$0.03 | -$0.02 | -$0.14 |
Previous Mean | -$0.06 | -$0.03 | -$0.02 | -$0.14 |
Standard Deviation | 0.03 | 0.04 | 0.06 | N/A |
Low Estimate | -$0.08 | -$0.07 | -$0.08 | -$0.14 |
High Estimate | -$0.02 | $0.00 | $0.03 | -$0.14 |